Based on the Wall Street analyst consensus for 40 of KMVAX’s holdings.
KMVAX Analyst Price Target
Average Price Target
$49.32▲(31.77% Upside)
Based on Wall Street analyst 12-month price targets for 40 of Kirr Marbach Partners Value Fund’s holdings in the last 3 months. The average price target is $49.32 with a high forecast of $60.28 and a low forecast of $40.70. The average price target represents a 31.77% change from the last price of $37.43.
Past 12 Months12 Month ForecastFeb2026Nov2026
High$60.28
Average$49.32
Low$40.70
Past 12 Months12 Month Forecast$34$40.8$47.5$54.3$61Feb2026May2026Aug2026Nov2026Nov2027
What is KMVAX’s average 12-month price target, according to analysts?
Based on Wall Street analyst price targets for 40 of KMVAX’s holdings, Kirr Marbach Partners Value Fund’s 12-month average price target is $49.32.
What is KMVAX’s upside potential, based on the analysts’ average price target?
KMVAX’s average price target of $49.32 represents a 31.77% upside from its last price of $37.43.
Is KMVAX a Buy, Sell or Hold?
Kirr Marbach Partners Value Fund has a consensus rating of Strong Buy, based on the analyst consensus for 40 of KMVAX’s holdings: 35 rated Buy, 5 rated Hold and 0 rated Sell.
What is Kirr Marbach Partners Value Fund’s price target?
The average price target for Kirr Marbach Partners Value Fund is $49.32, based on Wall Street analyst 12-month price targets for 40 of KMVAX’s holdings, issued in the past 3 months. The highest price target is $60.28 and the lowest is $40.70. The average price target represents a 31.77% increase from the last price of $37.43.
How can I buy shares of KMVAX?
You can buy shares of KMVAX through a brokerage account. Compare brokers on our Best Online Brokers page.